HEMATOLOGY

Latest News

Tagraxofusp Yields Deep Responses as Frontline BPDCN Therapy
Tagraxofusp Yields Deep Responses as Frontline BPDCN Therapy

June 10th 2025

During a live event, Gary J. Schiller, MD, explored the outcomes of the phase 1/2 trial of tagraxofusp-erzs in patients with blastic plasmacytoid dendritic cell neoplasm.

ICT01 Boosts AML Remission and Survival in EVICTION Trial
ICT01 Boosts AML Remission and Survival in EVICTION Trial

June 5th 2025

Unique Diagnostic Profile for BPDCN Warrants Focus on Hematopathology
Unique Diagnostic Profile for BPDCN Warrants Focus on Hematopathology

May 28th 2025

Phase 1 GTB-3650 Trial Advances for CD33+ Malignancies
Phase 1 GTB-3650 Trial Advances for CD33+ Malignancies

May 22nd 2025

Study Indicates Early Resolution of CRS, Neurological Events After Axi-Cel
Study Indicates Early Resolution of CRS, Neurological Events After Axi-Cel

May 1st 2025

More News